- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02053233
Robot-assisted Training for Stroke Recovery
Clinical Trial of Robot-assisted Training for Motor and Gait Recovery in Patients With Stroke
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Yangsan, Korea, Republic of, 626-770
- Pusan National University Yangsan Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- The subjects (age>19) with stroke 4 weeks after the onset but within 12 months were included.
Exclusion Criteria:
- Participated in the clinical studies, or received the rehabilitation therapy or therapy associated with the rehabilitation for the purpose of motor function improvement within thirty days before the start of this study.
- Cognitive disabilities or serious psychiatric illness.
- Difficulty in walking due to orthopedic problems.
- Ejection fraction less than 30% due to severe heart disease or with a diagnosis of unstable angina.
- Weight more than 135 kg or height less than 150 cm.
- Pregnancy subjects.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Walkbot group
The Walkbot group received conventional physical therapy (session I for 40 min/day) companied with Walkbot training (session II for 30 min/day) 5 days a week for 4 weeks, 40 session in all.
After 4-week intervention all subjects received conventional physical therapy only, 40 min/day, 5 days/week for 4 weeks.
|
The physiotherapist typed patient's information then Walkbot would adjust itself to this data and the exoskeleton legs lengthen or shorten to the patient. The computer screen would provide information about speed, duration, cadence and distance. The monitor in front of the patient can offer image and feedback during the therapy process for patients. The whole Walkbot training process was observed by one physiotherapist and should be always ready to adjust the unloading, duration, speed and guidance force of Walkbot according to patients' different situation such as muscle spasticity, gait quality, labor-consuming and observe the changes of patients' state.
Other Names:
|
|
PLACEBO_COMPARATOR: control group
The control group received conventional functional rehabilitation for 40 min/session, 2 sessions/day, 5 days/week for 4 weeks, 40 sessions in all.
After 4-week intervention all subjects received conventional physical therapy only, 40 min/day, 5 days/week for 4 weeks.
During the test period, general rehabilitation and drug treatment can be done at the same time.
|
The control group received conventional functional rehabilitation for 40 min/session, 2 sessions/day, 5 days/week for 4 weeks, 40 sessions in all.
After 4-week intervention all subjects received conventional physical therapy only, 40 min/day, 5 days/week for 4 weeks.
During the test period, general rehabilitation and drug treatment can be done at the same time.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
function ambulation category (FAC)
Time Frame: within 4 weeks after robot training
|
Function ambulation category was used for evaluating gait function.
The outcome variable were measured immediately before treatment start (pre-training), 4 weeks after treatment (post-training) and 4 weeks after robot-treatment (follow-up).
All the evaluations were done by the same professional therapist who was blind to the two group assignment.
|
within 4 weeks after robot training
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Berg balance scale (BBS)
Time Frame: within 4 weeks after robot training
|
Berg balance scale (BBS) were used for evaluating functional performance level after training.
The outcome variables were measured immediately before treatment start (pre-training), 4 weeks after treatment (post-training) and 4 weeks after robot-treatment (follow-up).
All the evaluations were done by the same professional therapist who was blind to the two group assignment.
|
within 4 weeks after robot training
|
|
Korean modified Barthel index (K-MBI)
Time Frame: within 4 weeks after robot training
|
Korean modified Barthel index (K-MBI) were used for evaluating functional performance level after training.
The outcome variables were measured immediately before treatment start (pre-training), 4 weeks after treatment (post-training) and 4 weeks after robot-treatment (follow-up).
All the evaluations were done by the same professional therapist who was blind to the two group assignment.
|
within 4 weeks after robot training
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
EuroQol-5 dimension (EQ-5D)
Time Frame: within 4 weeks after robot training
|
EuroQol-5 dimension (EQ-5D) was used for evaluating the effect of robot training to quality of life.
The outcome variable was measured immediately before treatment start (pre-training), 4 weeks after treatment (post-training) and 4 weeks after robot-treatment (follow-up).
All the evaluations were done by the same professional therapist who was blind to the two group assignment.
|
within 4 weeks after robot training
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PNUYH-03-2013-011
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
Clinical Trials on Walkbot group
-
Veterans Health Service Medical Center, Seoul,...CompletedStrokeKorea, Republic of
-
Burke Medical Research InstituteP&S Mechanics Co., Ltd.Completed
-
P&S Mechanics Co., Ltd.CompletedStrokeKorea, Republic of
-
Universidad de MurciaCompleted
-
Tanta UniversityCompletedChildren | Dexmedetomidine | Adenotonsillectomy | MidazolamEgypt
-
Tanta UniversityNot yet recruitingMelatonin | Doxorubicin | Vitamin D Concentration | Breast Cancer Patients DiagnosedEgypt
-
Charite University, Berlin, GermanyDepartment of Neurology, Charité - Universitätsmedizin Berlin, Germany; Department...Unknown
-
University of Sao Paulo General HospitalCompletedOsteoarthritis, Knee
-
National Yang Ming Chiao Tung UniversityCompleted
-
Cairo UniversityCompleted